Sepsis therapies: learning from 30 years of failure of translational research to propose new leads
Abstract Sepsis has been identified by the World Health Organization (WHO) as a global health priority. There has been a tremendous effort to decipher underlying mechanisms responsible for organ failure and death, and to develop new treatments. Despite saving thousands of animals over the last three...
Saved in:
| Main Authors: | Jean‐Marc Cavaillon, Mervyn Singer, Tomasz Skirecki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2020-03-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201810128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spleen tyrosine kinase: a novel pharmacological target for sepsis-induced cardiac dysfunction and multi-organ failure
by: Chiara Verra, et al.
Published: (2024-11-01) -
New Approaches to Treat Sepsis: Animal Models «Do Not Work» (Review)
by: Jean-Marc Cavaillon
Published: (2018-07-01) -
Immune correction in patients with sepsis (literature review)
by: A. V. Stepanov, et al.
Published: (2024-04-01) -
Extracorporeal Cytokine Adsorption in Sepsis: Current Evidence and Future Perspectives
by: Matteo Guarino, et al.
Published: (2025-07-01) -
Longitudinal Changes in Peripheral and Alveolar Monocyte and Inflammatory Biomarkers are Distinct in Hypercapnia Patients Following Pulmonary Sepsis-Induced ARDS
by: Zhao J, et al.
Published: (2025-04-01)